Form 4: Director Steven Denbaars Sells Aeluma Shares

Director Steven Denbaars sold 25,000 shares of Aeluma, Inc. common stock via a pre-arranged Rule 10b5-1 trading plan.

Summary

• Director Steven Denbaars executed a series of sales of Aeluma, Inc. (ALMU) common stock on May 19 and May 20, 2026.
• A total of 25,000 shares were sold across four transactions.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on November 20, 2025.
• Following these transactions, the reporting person retains beneficial ownership of 370,209 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sales were conducted under a pre-planned 10b5-1 arrangement, which is standard practice for corporate insiders.

Positives

• The sales were executed pursuant to a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for insiders to sell stock without concerns regarding non-public information.

Negatives

• The sale represents a reduction in the director's equity stake in the company.

Risks

• Insider selling can sometimes be perceived by the market as a lack of confidence in the short-term price appreciation of the stock.

Future Outlook

No forward-looking guidance or operational outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a routine corporate governance practice and generally does not signal a change in company fundamentals or strategic direction.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate insiders to manage liquidity while maintaining compliance with SEC regulations.

Stakeholder Impact

• Shareholders should note the reduction in insider holdings, though the pre-planned nature of the sale mitigates concerns regarding insider sentiment.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Aeluma, ALMU, Insider Trading, Form 4, Steven Denbaars, Rule 10b5-1